Safety and effectiveness data: Will children gain access?

Saved in:
Bibliographic Details
Published in:The American heart journal 1998-07, Vol.136 (1), p.4-5
Main Author: Schreiner, Mark S.
Format: Article
Language:English
Subjects:
Adrenergic beta-Antagonists - therapeutic use
Child
Female
Heart Failure - drug therapy
Heart Failure - physiopathology
Humans
Metoprolol - therapeutic use
Pregnancy
Safety
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c360t-faf4c700b07479134a3b2bb77710d34fceb696a3d32413929df23fb6e3f588cc3
cites cdi_FETCH-LOGICAL-c360t-faf4c700b07479134a3b2bb77710d34fceb696a3d32413929df23fb6e3f588cc3
container_end_page 5
container_issue 1
container_start_page 4
container_title The American heart journal
container_volume 136
creator Schreiner, Mark S.
description
doi_str_mv 10.1016/S0002-8703(98)70173-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80005649</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870398701735</els_id><sourcerecordid>80005649</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-faf4c700b07479134a3b2bb77710d34fceb696a3d32413929df23fb6e3f588cc3</originalsourceid><addsrcrecordid>eNqFkEtLAzEUhYMotVZ_QmFWoovRZJJJJm5Eii8ouKjiMmSSG41MZ2oyLfTfmz7o1tXlcs65l_MhNCb4hmDCb2cY4yKvBKZXsroWmAial0doSLAUOReMHaPhwXKKzmL8SSsvKj5AA8l5WRA8RHKmHfTrTLc2A-fA9H4FLcSYWd3ru-zTN01mvn1jA7TZl_Ztpo1J-v05OnG6iXCxnyP08fT4PnnJp2_Pr5OHaW4ox33utGNGYFxjwYQklGlaF3UthCDYUuYM1FxyTS0tGKGykNYV1NUcqCuryhg6Qpe7u4vQ_S4h9mruo4Gm0S10y6iq1KrkTCZjuTOa0MUYwKlF8HMd1opgtUGmtsjUhoeSldoiU2XKjfcPlvUc7CG1Z5T0-50OqeXKQ1DReGgNWB8SL2U7_8-HP1c5ecw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80005649</pqid></control><display><type>article</type><title>Safety and effectiveness data: Will children gain access?</title><source>ScienceDirect Freedom Collection</source><creator>Schreiner, Mark S.</creator><creatorcontrib>Schreiner, Mark S.</creatorcontrib><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/S0002-8703(98)70173-5</identifier><identifier>PMID: 9665210</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Child ; Female ; Heart Failure - drug therapy ; Heart Failure - physiopathology ; Humans ; Metoprolol - therapeutic use ; Pregnancy ; Safety ; Treatment Outcome</subject><ispartof>The American heart journal, 1998-07, Vol.136 (1), p.4-5</ispartof><rights>1998 Mosby, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-faf4c700b07479134a3b2bb77710d34fceb696a3d32413929df23fb6e3f588cc3</citedby><cites>FETCH-LOGICAL-c360t-faf4c700b07479134a3b2bb77710d34fceb696a3d32413929df23fb6e3f588cc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9665210$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schreiner, Mark S.</creatorcontrib><title>Safety and effectiveness data: Will children gain access?</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Child</subject><subject>Female</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - physiopathology</subject><subject>Humans</subject><subject>Metoprolol - therapeutic use</subject><subject>Pregnancy</subject><subject>Safety</subject><subject>Treatment Outcome</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkEtLAzEUhYMotVZ_QmFWoovRZJJJJm5Eii8ouKjiMmSSG41MZ2oyLfTfmz7o1tXlcs65l_MhNCb4hmDCb2cY4yKvBKZXsroWmAial0doSLAUOReMHaPhwXKKzmL8SSsvKj5AA8l5WRA8RHKmHfTrTLc2A-fA9H4FLcSYWd3ru-zTN01mvn1jA7TZl_Ztpo1J-v05OnG6iXCxnyP08fT4PnnJp2_Pr5OHaW4ox33utGNGYFxjwYQklGlaF3UthCDYUuYM1FxyTS0tGKGykNYV1NUcqCuryhg6Qpe7u4vQ_S4h9mruo4Gm0S10y6iq1KrkTCZjuTOa0MUYwKlF8HMd1opgtUGmtsjUhoeSldoiU2XKjfcPlvUc7CG1Z5T0-50OqeXKQ1DReGgNWB8SL2U7_8-HP1c5ecw</recordid><startdate>19980701</startdate><enddate>19980701</enddate><creator>Schreiner, Mark S.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980701</creationdate><title>Safety and effectiveness data: Will children gain access?</title><author>Schreiner, Mark S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-faf4c700b07479134a3b2bb77710d34fceb696a3d32413929df23fb6e3f588cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Child</topic><topic>Female</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - physiopathology</topic><topic>Humans</topic><topic>Metoprolol - therapeutic use</topic><topic>Pregnancy</topic><topic>Safety</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schreiner, Mark S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schreiner, Mark S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety and effectiveness data: Will children gain access?</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>1998-07-01</date><risdate>1998</risdate><volume>136</volume><issue>1</issue><spage>4</spage><epage>5</epage><pages>4-5</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><cop>United States</cop><pub>Mosby, Inc</pub><pmid>9665210</pmid><doi>10.1016/S0002-8703(98)70173-5</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 1998-07, Vol.136 (1), p.4-5
issn 0002-8703
1097-6744
language eng
recordid cdi_proquest_miscellaneous_80005649
source ScienceDirect Freedom Collection
subjects Adrenergic beta-Antagonists - therapeutic use
Child
Female
Heart Failure - drug therapy
Heart Failure - physiopathology
Humans
Metoprolol - therapeutic use
Pregnancy
Safety
Treatment Outcome
title Safety and effectiveness data: Will children gain access?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T00%3A50%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20and%20effectiveness%20data:%20Will%20children%20gain%20access?&rft.jtitle=The%20American%20heart%20journal&rft.au=Schreiner,%20Mark%20S.&rft.date=1998-07-01&rft.volume=136&rft.issue=1&rft.spage=4&rft.epage=5&rft.pages=4-5&rft.issn=0002-8703&rft.eissn=1097-6744&rft_id=info:doi/10.1016/S0002-8703(98)70173-5&rft_dat=%3Cproquest_cross%3E80005649%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c360t-faf4c700b07479134a3b2bb77710d34fceb696a3d32413929df23fb6e3f588cc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=80005649&rft_id=info:pmid/9665210&rfr_iscdi=true